文献速递心脑血管急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

肺超声B线评分对急性心力衰竭的诊断价值

[Diagnostic value of lung ultrasound B-line score in acute heart failure].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2018-01-01
一句话结论在ICU急性呼吸困难成人中,肺超声B线评分以8.5为界诊断急性心力衰竭特异度95%、敏感度77.8%,AUC 0.917,略低于血浆BNP的AUC 0.979。

本研究为回顾性分析,纳入2016年1月至2017年6月南京中医药大学附属医院ICU的急性呼吸困难成人患者56例(男32例、女24例,平均年龄77.3±8.8岁),均行8区肺超声并检测血浆BNP,由两名有经验的ICU医生根据急性心力衰竭诊断标准确定最终诊断,分为急性心力衰竭组36例与非急性心力衰竭组。急性心力衰竭组BNP(ng/L)为1640.4±1078.4、B线评分为12.8±5.3,均高于非急性心力衰竭组的236.9±124.9和5.4±1.8(均P<0.01)。BNP升高与B线评分增加呈强相关(R²=0.712,P=0.000)。B线评分以8.5为界值时,敏感度77.8%、特异度95%、阳性似然比15.56、阴性似然比0.23,AUC为0.917(95%CI 0.847-0.987,P=0.000),略低于血浆BNP的AUC 0.979(95%CI 0.951-1.008)。作者认为肺超声B线评分对急性心力衰竭识别具有高特异度、中等敏感度。

要点

  • ICU急性呼吸困难成人中,急性心力衰竭组B线评分12.8±5.3 vs 非急性心力衰竭组5.4±1.8(P<0.01);BNP(ng/L)1640.4±1078.4 vs 236.9±124.9(P<0.01)。
  • B线评分以8.5为界诊断急性心力衰竭:敏感度77.8%、特异度95%、阳性似然比15.56、阴性似然比0.23。
  • B线评分诊断急性心力衰竭AUC 0.917(95%CI 0.847-0.987,P=0.000),略低于血浆BNP的AUC 0.979(95%CI 0.951-1.008)。
  • BNP升高与B线评分增加呈强相关(R²=0.712,P=0.000)。
  • 作者认为肺超声B线评分对急性心力衰竭识别具有高特异度、中等敏感度。

适用人群与场景

  • 2016年1月至2017年6月南京中医药大学附属医院ICU收治的急性呼吸困难成人患者,共56例,男32例、女24例,平均年龄77.3±8.8岁,其中急性心力衰竭36例、非急性心力衰竭20例。

诊断标准与关键阈值

  • 急性心力衰竭由两名有经验的ICU医生根据急性心力衰竭诊断标准确定最终诊断。
  • 肺超声B线评分以8.5为界值区分急性心力衰竭与其他原因所致呼吸困难(原文报告该界值下敏感度77.8%、特异度95%)。

研究设计与关键结果

  • 研究类型为回顾性分析,纳入ICU急性呼吸困难成人56例(急性心力衰竭36例、非急性心力衰竭20例),均行8区肺超声并检测血浆BNP。
  • 急性心力衰竭组BNP(ng/L)1640.4±1078.4 vs 非急性心力衰竭组236.9±124.9(P<0.01);B线评分12.8±5.3 vs 5.4±1.8(P<0.01)。
  • BNP升高与B线评分增加呈强相关(R²=0.712,P=0.000)。
  • B线评分以8.5为界诊断急性心力衰竭:敏感度77.8%、特异度95%、阳性似然比15.56、阴性似然比0.23;AUC 0.917(95%CI 0.847-0.987,P=0.000),略低于血浆BNP的AUC 0.979(95%CI 0.951-1.008)。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为肺超声B线评分对急性心力衰竭识别具有高特异度、中等敏感度。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the value of bedside lung ultrasound B-line score in the diagnosis of acute heart failure (AHF).

METHODS: A retrospectively analysis was conducted. The adult patients presenting with acute dyspnea in intensive care unit (ICU) of Affiliated Hospital of Nanjing University of Traditional Chinese Medicine from January 2016 to June 2017 were enrolled. An 8-zone lung ultrasound was performed and plasma B-type natriuretic peptide (BNP) level was tested in all patients. AHF was determined as the final diagnosis by two experienced ICU doctors according to the diagnostic criteria of AHF. Patients were divided into two groups: AHF group and non-AHF group. The levels of BNP and B-line score were compared between the two groups, and the diagnostic value of BNP and B-line score in AHF was evaluated.

RESULTS: Fifty-six patients were included in this study, with 32 of men and 24 of women, and with an average age of 77.3±8.8. Thirty-six patients were diagnosed as AHF. The level of BNP and lung ultrasound B-line score in AHF group were higher than those in non-AHF group [BNP (ng/L): 1 640.4±1 078.4 vs. 236.9±124.9, B line score: 12.8±5.3 vs. 5.4±1.8, both P < 0.01]. There was a strong correlation between elevated BNP levels and an increased B-lines score (R2 = 0.712, P = 0.000). The receiver operating characteristic curve (ROC) showed that when the cut-off of lung ultrasound B-line score was 8.5, AHF could be discriminated from dyspnea caused by other diseases (sensitivity was 77.8%, specificity was 95%, positive likelihood ratio was 15.56, negative likelihood ratio was 0.23). The area under the ROC curve (AUC) of lung ultrasound B-line score was 0.917 [95% confidence interval (95%CI) = 0.847-0.987, P = 0.000], slightly lower than that of plasma BNP [0.979 (95%CI = 0.951-1.008)].

CONCLUSIONS: Lung ultrasound B-line score was highly specific, but moderately sensitive for identifying patients with AHF.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhuang Y, Dai L, Chen M, et al. [Diagnostic value of lung ultrasound B-line score in acute heart failure]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29402366. doi:10.3760/cma.j.issn.2095-4352.2018.02.012

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。